Feb 19, 2026 First Group Leaders announced for new dedicated Parkinson's Research Centre In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research... Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Search for keywords Condition ConditionAlzheimer's diseaseFrontotemporal dementiaHuntington's diseaseLewy body dementiaMild cognitive impairmentMotor neuron disease/ALSOther conditionsParkinson's diseaseVascular dementia Techniques TechniquesAdvanced microscopy & imagingAdvanced spectroscopyBioinformaticsBiophysical techniquesCRISPRDrug screeningElectrophysiologyEpigenomicsExperimental medicineFlow cytometryFluid biomarkersGenomicsHuman brain imagingLipidomicsMass spec-based proteomicsMetabolomicsMouse behaviourMouse in vivo imagingNext generation sequencingNon-mammalian animal modelsOptogeneticsRobotics & environmental sensingSingle cell / nucleus transcriptomicsSoftware developmentSpatial transcriptomicsStatistical modellingStem cells / iPSCsStructural biologyTranscranial brain stimulationViral-mediated expression Research Division Research Division Prof Edward Avezov Group Leader UK DRI at Cambridge Investigating the roles of the endoplasmic reticulum in helping maintain neuronal health, and its role in disease Learn more Prof Edward Avezov Dr Tim Bartels Group Leader UK DRI at UCL Untangling protein structure to better understand function and treat neurodegeneration Learn more Dr Tim Bartels Dr Kathryn Bowles Group Leader UK DRI at Edinburgh Deciphering what happens within our cells when there is a mutation in the tau gene Learn more Dr Kathryn Bowles Prof Bart De Strooper Group Leader UK DRI at UCL Investigating the cellular reaction to amyloid beta and tau protein in Alzheimer's disease Learn more Prof Bart De Strooper Prof David Klenerman Group Leader UK DRI at Cambridge Determining how protein clumps form, damage the brain and change as the different neurodegenerative diseases develop to know which ones to target for therapies Learn more Prof David Klenerman Dr Tom Massey Group Leader UK DRI at Cardiff Using recent genetic discoveries to develop new drug targets for Huntington's disease Learn more Dr Tom Massey Dr Will McEwan Group Leader UK DRI at Cambridge Deciphering the mechanisms of tau accumulation and exploring new methods for treatment of tauopathies Learn more Dr Will McEwan Prof Miratul Muqit Centre Director Parkinson's Research Centre at the University of Edinburgh Learn more Prof Miratul Muqit Prof David Rubinsztein Group Leader & Research Division Lead UK DRI at Cambridge Deciphering the link between neurodegeneration and autophagy Learn more Prof David Rubinsztein Prof Giampietro Schiavo Group Leader & Research Division Lead UK DRI at UCL Restoring axonal transport deficits as a therapeutic strategy for neurodegenerative diseases Learn more Prof Giampietro Schiavo Dr Andrea Serio Group Leader UK DRI at King's Combining bioengineering, imaging, and stem cell modelling to better understand motor neuron disease and dementia Learn more Dr Andrea Serio Prof Chris Shaw Group Leader UK DRI at King's Proteostatic mechanisms in FTD and ALS Learn more Prof Chris Shaw Pagination Current page 1 Page 2 Next page › Last page Last
Prof Edward Avezov Group Leader UK DRI at Cambridge Investigating the roles of the endoplasmic reticulum in helping maintain neuronal health, and its role in disease Learn more Prof Edward Avezov
Dr Tim Bartels Group Leader UK DRI at UCL Untangling protein structure to better understand function and treat neurodegeneration Learn more Dr Tim Bartels
Dr Kathryn Bowles Group Leader UK DRI at Edinburgh Deciphering what happens within our cells when there is a mutation in the tau gene Learn more Dr Kathryn Bowles
Prof Bart De Strooper Group Leader UK DRI at UCL Investigating the cellular reaction to amyloid beta and tau protein in Alzheimer's disease Learn more Prof Bart De Strooper
Prof David Klenerman Group Leader UK DRI at Cambridge Determining how protein clumps form, damage the brain and change as the different neurodegenerative diseases develop to know which ones to target for therapies Learn more Prof David Klenerman
Dr Tom Massey Group Leader UK DRI at Cardiff Using recent genetic discoveries to develop new drug targets for Huntington's disease Learn more Dr Tom Massey
Dr Will McEwan Group Leader UK DRI at Cambridge Deciphering the mechanisms of tau accumulation and exploring new methods for treatment of tauopathies Learn more Dr Will McEwan
Prof Miratul Muqit Centre Director Parkinson's Research Centre at the University of Edinburgh Learn more Prof Miratul Muqit
Prof David Rubinsztein Group Leader & Research Division Lead UK DRI at Cambridge Deciphering the link between neurodegeneration and autophagy Learn more Prof David Rubinsztein
Prof Giampietro Schiavo Group Leader & Research Division Lead UK DRI at UCL Restoring axonal transport deficits as a therapeutic strategy for neurodegenerative diseases Learn more Prof Giampietro Schiavo
Dr Andrea Serio Group Leader UK DRI at King's Combining bioengineering, imaging, and stem cell modelling to better understand motor neuron disease and dementia Learn more Dr Andrea Serio
Prof Chris Shaw Group Leader UK DRI at King's Proteostatic mechanisms in FTD and ALS Learn more Prof Chris Shaw
